Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

Summary

The purpose of this study is to find the safest dose level of an approved drug, carfilzomib, in solid tumors when given over a different period of time than normally used. The study will also use markers in blood from routine blood draws to help check the levels of the drug. Lastly, the study will check how well this drug works with regards to keeping cancer cells from growing with the new time frame of delivery.

Timeline

Start

2014-08

Primary completion

2016-11

Completion

2016-11

Drugs

Indications